AIG
VYNE icon

American International Group’s VYNE Therapeutics VYNE Stock Holding History

American International Group’s Portfolio VYNE Stock Details VYNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,175
Closed -$145 – 3281
2021
Q1 		$145 Buy
1,175
+3
+0.3% +$435 ﹤0.01% 2531
2020
Q4 		$133 Sell
1,172
-34
-3% -$4.27K ﹤0.01% 2506
2020
Q3 		$144K Buy
1,206
+301
+33% +$35.1K ﹤0.01% 2326
2020
Q2 		$113K Buy
905
+524
+138% +$71K ﹤0.01% 2461
2020
Q1 		$74K Buy
381
+246
+182% +$77.2K ﹤0.01% 2491
2019
Q4 		$45K Sell
135
-1
-0.7% -$333 ﹤0.01% 2907
2019
Q3 		$44K Sell
136
-1
-0.7% -$323 ﹤0.01% 2922
2019
Q2 		$59K Buy
137
+51
+59% +$25.2K ﹤0.01% 2904
2019
Q1 		$49K Sell
86
-2
-2% -$960 ﹤0.01% 2880
2018
Q4 		$26K Sell
88
-1
-1% -$448 ﹤0.01% 2996
2018
Q3 		$63K Buy
89
+31
+53% +$19.1K ﹤0.01% 3014
2018
Q2 		$34K Buy
58
+1
+2% +$777 ﹤0.01% 3026
2018
Q1 		$154K Buy
+57
New +$139K ﹤0.01% 2413

Other funds holding VYNE

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HVC
Healthcare Value Capital Woodcliff Lake, New Jersey $50.7M AUM 24.72% 1-Year Est. Return

American International Group's VYNE Position: Q2 2021 in Review

American International Group sold out of VYNE Therapeutics (VYNE) in Q2 2021, closing a stake of 1,175 shares — an estimated $145 sold.

American International Group first reported a position in VYNE in Q1 2018 and held it in 13 quarters. The position peaked at $154K in Q1 2018. 72 funds tracked by Wall St. Rank hold VYNE as of Q2 2021.

  • American International Group reported no remaining VYNE Therapeutics position as of Q2 2021 after selling out during the quarter.
  • American International Group sold 1,175 VYNE Therapeutics shares in Q2 2021, an estimated $145.
  • American International Group first reported a position in VYNE Therapeutics in Q1 2018 and held it in 13 quarters.
  • American International Group's VYNE Therapeutics position peaked at $154K in Q1 2018.
  • 72 funds tracked by Wall St. Rank held VYNE Therapeutics as of Q2 2021.

Based on American International Group's 13F filing for Q2 2021, filed 13 Aug 2021.